Influence of chemotherapy on women's sexuality | ||||
Egyptian Journal of Health Care | ||||
Article 26, Volume 9, Issue 2, June 2018, Page 342-350 PDF (215.33 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejhc.2018.163278 | ||||
View on SCiNiTO | ||||
Authors | ||||
Omnya M.1; Nadia M.2; Nevin S2; Amal T2; Amr L3 | ||||
1BSC., Nursing science Faculty of Nursing and Medicine, Ain Shams University | ||||
2Maternal & Gynecological Nursing Faculty of Nursing and Medicine, Ain Shams University | ||||
3Clinical Oncology Faculty of Nursing and Medicine, Ain Shams University | ||||
Abstract | ||||
This study was aimed to assess the influence of chemotherapy on women's sexuality. Design: A descriptive study. Setting: The study was conducted at Radiation Oncology & Nuclear Medicine Center - Ain Shams Hospitals. Sample: The subjects for the study were (106) women who had a cancer diagnosis and received chemotherapy. Data collection tools: Structured interviewing questionnaire sheet and Female Sexual Function Index. Result: more than half of the sample are at age categories (36-45), near half of them had breast cancer, near half of them underwent chemotherapy for more than 6months, more than half of them not had sex, and the majority of them had Sexual dysfunction related to chemotherapy. Moreover, there was statistically significant relation between FSFI and chemotherapy duration. Conclusion: significant sexual dysfunction in women after treatment with chemotherapy. Recommendation: providing guidelines, programs and counseling regarding sexual health is becoming mandatory in the oncology units in order to improve sexual life of women with cancer and under chemotherapy. | ||||
Keywords | ||||
Cancer; Chemotherapy; Sexual Dysfunction; Female Sexual Function Index (FSFI) | ||||
Statistics Article View: 86 PDF Download: 60 |
||||